Comments
Loading...

Entero Therapeutics

ENTONASDAQ
Logo brought to you by Benzinga Data
$0.489800
-0.05-9.30%
At close: -
$0.489300
-0.0005-0.10%
After Hours: 5:14 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
Journey Therapeutics, Inc announced it will be merged with Entero Therapeutics (ENTO) on Wednesday, November 13, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock, Short Interest Report

Short interest in Entero Therapeutics Inc (NASDAQ:ENTO) decreased during the last reporting period, falling from 295.78K to 94.02K. This put 1.98% of the company's publicly available shares short.

Short interest for Entero Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Entero Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 376.68K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.

Short Interest
94.02K
Short Interest %
1.98%
Days to Cover
1
Data brought to you by Benzinga APIs

Looking for the most shorted stocks?

People Also Watch